As expected, there was a decrease in miR-130a expression and an increase in TSC1 levels in xenografts treated with antagomiR-130a compared to mock treated ones (Fig. 8d), which further confirms that the reduced tumor growth in nude mice is due to the targeting of 3′UTR of TSC1 by miR-130a. The gene discussed is TSC1; the disease is neoplasm.